News Focus
News Focus
Followers 22
Posts 4084
Boards Moderated 0
Alias Born 04/29/2016

Re: Saltz post# 11276

Thursday, 02/23/2017 11:41:24 AM

Thursday, February 23, 2017 11:41:24 AM

Post# of 236582
Nice post Saltz. Yes, I do want to see some stellar and compelling Adjunct PE data.. It will also be reassuring that we are granted BTD. I shared some slides yesterday that demonstrated BTD approvals = 90% ongoing FDA marketed approvals. However, if not BTD approved..many still were eventually granted FDA marketing approval..especially the compounds that had a Fast Tract status. Let's get Adjunct locked and Loaded..then on to more lucrative valuations. Obviously, one catalyst at a time will build value in this equity. I am very disappointed in the volume of shares being traded Post CROI (i.e..Interest)...what is up with that?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News